Importance of snake venom metalloproteinases in cell biology: Effects on platelets, inflammatory and endothelial cells

Current Pharmaceutical Design

Volumn 13, Issue 28, 2007, Pages 2893-2905

  Moura da Silva, A M ^a   Butera, D ^a   Tanjoni, I ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Angiogenesis; Apoptosis; Collagen; Cytokine; Disintegrin; Endothelial cell; Inflammation; Integrin; Platelet; Venom metalloproteinases

Indexed keywords

ACURHAGIN; ALTERNAGIN C; ANTIINFLAMMATORY AGENT; ATROLYSIN A; BERYTHRACTIVASE; BRINASE; CATROCOLLASTIN; CROVIDISIN; EPTIFIBATIDE; GRAMINELYSIN I; HALYDIN; HALYSASE; JARARHAGIN; JARARHAGIN C; KAOUTHIAGIN; KISTOMIN; METALLOPROTEINASE; MONOCROTALINE; NATURAL PRODUCT; PROTEIN BAP1; PROTEIN EOVMP2; PROTEIN EOVMP3; PROTEIN HF3; RHODOSTOMIN; SNAKE VENOM; TIROFIBAN; TRIFLAMP; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENOM ANTISERUM; VIPER VENOM; AUTACOID;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; ANOIKIS; APOPTOSIS; BINDING AFFINITY; BINDING COMPETITION; BIOLOGICAL ACTIVITY; CELL INTERACTION; CYTOKINE RELEASE; CYTOLOGY; CYTOTOXICITY; DISEASE EXACERBATION; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; EDEMA; ENDOTHELIUM CELL; ENVENOMATION; ENZYME ISOLATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FIBRINOLYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMOSTASIS; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LETHAL DOSE; MACROPHAGE ACTIVATION; MECHANOTRANSDUCTION; MOLECULAR MECHANICS; MUSCLE NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REVIEW; SKIN DEFECT; SNAKEBITE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; TOXICITY TESTING; ANIMAL; CHEMISTRY; ENZYMOLOGY; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; METALLOPROTEASES; SNAKE VENOMS;

EID: 38449120854     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207782023711     Document Type: Review

References (118)

1. Cardoso JLC, Fan HW, França FOS, Jorge MT, Leite RP, Nishioka SA, et al. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. QJM 1993; 86: 315-25.
2. Faiz MA, Falkous G, Harris JB, Mantle D. Comparison of protease and related enzyme activities in snake venoms. Comp Biochem Physiol B 1996; 113: 119-204.
3. Gutiérrez JM, Rucavado A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 2000; 82: 841-5.
4. Fox JW, Serrano SMT. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 2005; 45: 969-86.
5. Bode W, Gomis-Ruth FX, Stockler W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett 1993; 331: 134-40.
6. Stöcker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, et al. The metzincins - Topological and sequential relations between astacins, adamalysins, serralysins, and matrixins (collagenases) define a super family of zinc-peptidases. Protein Sci 1995; 4: 823-40.
7. Assakura MT, Reichl AP, Mandelbaum FR. Isolation and characterization of five fibrin(ogen)olytic enzymes from the venom of Philodryas olfersii (green snake). Toxicon 1994; 32: 819-31.
8. Kamiguti AS, Theakston RD, Sherman N, Fox JW. Mass spectrophotometric evidence for P-III/P-IV metalloproteinases in the venom of the Boomslang (Dispholidus typus). Toxicon 2000; 38: 1613-20.
9. Matsui T, Fujimura Y, Titani K. Snake venom proteases affecting hemostasis and thrombosis. Biochim, Biophys Acta 2000; 1477: 146-56.
10. Moura-da-Silva AM, Theakston RDG, Crampton JM. Evolution of disintegrin-like cystein-Rich and mammalian matrix-degrading metalloproteinases: gene duplication and divergence of a common ancestor rather than convergent evolution. J Mol Evol 1996; 43: 263-9.
11. Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J Biol Chem 1987; 262: 16157-63.
12. Calvete JJ, Marcinkiewicz C, Monleon D, Esteve V, Celda B, Juarez P, et al. Snake venom disintegrins: evolution of structure and function. Toxicon 2005; 45: 1063-74.
13. Paine MJI, Desmond HP, Theakston RDG, Crampton, JM. Purification, cloning and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. Insights into the disintegrin-like gene family. J Biol Chem 1992; 267: 22869-76.
14. Fox JW, Long C. In: Bailey G, Ed, The ADAMs/MDC family of proteins and their relationships to the snake venom metalloproteinases: Snake Venom Enzymes. Ft. Collins, CO, Alaken Press 1998; 151-78.
15. Gutiérrez JM, Rucavado A, Escalante T, Diaz C. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 2005; 45: 997-1012.
16. Laing G, Moura-Da-Silva AM. Jararhagin and its multiple effects on hemostasis. Toxicon 2005; 45: 987-96.
17. 1 and secondary mediators. J Throm Hemost 2003; 1: 1278-87.
18. Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 1986; 67: 322-30.
19. Kamiguti AS. Platelets as targets of snake venom metalloproteinases. Toxicon 2005; 45: 1041-9.
20. Watson SP, Gibbins JM. Collagén receptor signalling in platelets: extending the role of the ITAM. Immunol Today 1998; 19: 260-4.
21. Andrews RK, Gardiner EE, Shen Y, Berndt MC. Platelet interactions in thrombosis. IUBMB Life 2004; 56: 13-8.
22. Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol 1994; 31: 289-300.
23. Cheng JW. Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous. coronary intervention. Am J Health Syst Pharm 2002; 59: S5-14.
24. Marcinkiewics, C, Functional pharacteristic of snake venom disintegrins: potential therapeutic application. Curr Pharm Des 2005; 11: 815-27.
25. Kamiguti AS, Hay CRM, Theakston RDG, Zuzel M. Insights into the mechanism of hemorrhage caused by the snake venom metallo-proteinases. Taxicon 1996; 34: 627-42.
26. Mascelli MA, Kirby EP. Proteolytic studies on the structure of bovine von Willebrand factor. Biochemistry 1988; 27: 1274-84.
27. Hamako J, Matsui T, Nishida S, Nomura S, Fujimura Y, Ito M, et al. Purification and characterization of kauthiagin, a von Wille-brand factor-binding and -cleaving metalloproteinase from Naja Kaouthia cobra venom. Thromb Haemost 1998; 80: 499-505.
28. Wang WJ, Huang TF. Purification and characterization of a novel metalloproteinase acurhagin, from Agkistrodon acutus venom. Thromb Haemost 2002; 87: 641-50.
29. Wu WB, Peng HC, Huang TF. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox. Thromb Haemost 2001; 86: 1501-11.
30. Huang TF, Chang JC, Teng CM. Antiplatelet protease, kistomin, selectively cleaves human glycoprotein Ib. Biochim Biophys Acta 1993; 1158: 293-9.
31. Ward CM, Andrews RK, Smith AI, Bernt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ib alpha. Identification of the sulphated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ib alpha as a binding site for von Willebrand factor and alpha thrombin. Biochemistry 1996; 35: 4929-38.
32. Tseng YL, Lee CJ, Huang TF. Effects of a snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: involvement of platelet GPIbalpha and neutrophil PSGL-1. Thromb Haemost 2004; 91: 315-24.
33. De Luca M, Dunlop LC, Andrews RK, Flannery JV Jr, Ettling R, Cumming DA, et al. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem 1995; 270: 26734-7.
34. Howes JM, Kamiguti AS, Theakston RDG, Wilkinson MC, Laing GD. Effects of three novel metalloproteinases from the venom of the West African saw-scaled viper, Echis ocellatus on blood coagulation and platelets. Biochim Biophys Acta 2005; 1724: 194-202.
35. 1. Biochem Biophys Res Commun 1995; 206: 570-6.
36. 1-integrin by the snake venom metalloproteinase jarararhagin. Biochem J 1996; 320: 635-41.
37. Liu CZ, Huang TF. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch Biochem Biophys 1997; 337: 291-9.
38. Zhou Q, Smith JB, Grossman MH. Molecular cloning and expression of catrocollastatin, a snake-venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen. Biochem J 1995; 307: 411-7.
39. Zhou Q, Dangelmaier C, Smith JB. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem Biophys Res Commun 1996; 219: 720-6.
40. Tanjoni I, Butera D, Bento L, Della-Casa MS, Marques-Porto R, Takehara HA, et al. Snake Venom Metalloproteinases: Structure/function relationships using monoclonal antibodies. Toxicon 2003; 42: 801-8.
41. Baramova EN, Shannon JD, Bjarnason JB, Fox JW. Degradation of extracellular matrix proteins by hemorrhagic metalloproteinases. Arch Biochem Biophys 1989; 275: 63-71.
42. Kamiguti AS, Slupsky JR, Zuzel M, Hay CR. Properties of fibrinogen cleaved by jararhagin, a metalloproteinase from the venom of Bothrops jararaca. Thromb Haemost 1994; 72: 244-9.
43. 1-integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72. J Biol Chem 1997; 272: 32599-605.
44. Usami Y, Fujimura Y, Miura S, Shima H, Yoshida E, Yoshioka A, et al. A 28-kDa protein with disintegrin-like-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen and ADP-induced platelet aggregation. Biochem Biophys Res Commun 1994; 201: 331-9.
45. Moura-da-Silva AM, Línica A, Della-Casa MS, Kamiguti AS, Ho PL, Crampton J M, et al. Jararhagin ECD-disintegrin-like domain: expression in Escherichia coli and inhibition of the platelet-collagen interaction. Arch Biochem Biophys 369; 1999: 295-301.
46. Shimokawa K, Shannon JD, Jia LG, Fox JW. Sequence and biological activity of catrocollastatin-C: a disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Arch Biochem Biophys 1997; 343: 35-43.
47. Kamiguti AS, Moura-da-Silva AM, Laing GD, Knapp T, Zuzel M, Crampton JM, et al. Collagen-induced secretion-dependent phase of platelet aggregation is inhibited-by the snake venom metalloproteinase jararhagin. Biochem Biophys Acta 1997; 1335: 209-17.
48. 1-integrin ω the induction of platelet protein tyrosine phosphorylation and aggregation. Arch Biochem Biophys 2000; 374: 356-62.
49. Kamiguti AS, Gallager P, Marcinkiewicz C, Theakston RGD, Zuzel M, Fox JW. Identification of sites in the cysteine-rich domain of the class P-III snake venom metalloproteinase responsible for the inhibition of platelet function. FEBS Lett 2003; 549: 129-34.
50. Jia LG, Wang XM, Shannon JD, Bjarnason JB, Fox JW. Function of disintegrin-like/cysteine-rich domains of atrolysin-A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. J Biol Chem 1997; 272: 13094-102.
51. You WK, Jang YJ, Chung KH, Kim DS. A novel disintegrin-like domain of a high molecular weight metalloprotease inhibits platelet aggregation. Biochem Biophys Res Commun 2003; 309: 637-42.
52. Fox JW, Bjanarson JB. Atrolysins: Metalloproteinases from Crotalus atrox venom. Methods Enzymol 1995; 248: 369-87.
53. Jia LG, Wang XM, Shannon JD, Bjarnason JB, Fox JW, Inhibition of platelet aggregation by the recombinant cysteine-rich domain of the hemorrhagic snake venom metalloproteinase, Atrolysin-A. Arch Biochem Biophys 2000; 373: 281-6.
54. Serrano SMT, Jia LG,Wang D, Shannon JD, Fox, JW. Function of the cysteine-rich domain of the hemorrhagic metalloproteinase atrolysin-A: targeting adhesion proteins collagen I and von Willebrand factor. Biochem J 2005; 391: 69-76.
55. 1 integrin. J Biol Chem 1999; 274: 3513-21.
56. Pentikainen O, Hoffren AM, Ivaska J, Käpylä J, Nyrönen T, Heino J, et al. "RKKH" peptides from the snake venom metalloproteinase of Bothrops jararaca bind near the metal ion-dependent adhesion site of the human integrin α2 I-domain. J Biol Chem 1999; 274: 31493-505.
57. Nymalm Y, Puranen JS, Nyholm TK, Kapyla J, Kidron H, Pentikain OT, et al. Jararhagin-derived "RKKH1" peptides induce structural changes in α1 I domain of himan integrin α1β1. J Biol Chem 206; 279: 7962-70.
58. 1 integrin by jararhagin, a metalloproteinase/disintegrin-like from Bothrops jararaca yenom. Thromb Res 2001; 102: 153-9.
59. Lukashev ME, Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 1998; 8: 437-41.
60. Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 2002; 91: 877-87.
61. Roy R, Zhang B, Moses MA. Making the cut: Protease-mediated regulation of angiogenesis. Exp Cell Res 2006; 312: 608-22.
62. Handsley MM, Edwards DR. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 2005; 115: 849-60.
63. Trochon-Joseph V, Martel-Renoir D, Mir L. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Cancer Res 2004; 64: 2062-9.
64. Vazquez F, Hastings G, Ortega MA. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999; 274: 23349-57.
65. Iruela-Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloproteinase with angioinhibitory properties. Ann N Y Acad Sci 2003; 995: 183-90.
66. Cornelius LA, Nehring LC, Harding E, Bolanowski M, Welgus HG, Kobayashi DK, et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 1998; 161: 6845-52.
67. Lin HC, Chang JH, Jain S, Gabison EE, Kure T, Kato T, et al. Matrilysin leavage of comeal collagen type XVIII NC1 domain and generation of a 28 kDa fragment. Invest. Ophthalmol Vis Sci 2001; 42: 2517-24.
68. Hamano Y, Zeisberg M, Sugimoto H, Lively J, Zeisberg M, Kalluri R. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 2003; 3: 589-601.
69. Brooks PC, Silletti S, Von Schalscha TL, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998; 92: 391-400.
70. Stupack DG, Cheresh DA. Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene 2003; 22: 9022-9.
71. Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002; 115: 3729-38.
72. Yeh CH, Peng HC, Huang TF. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood 1998; 92: 3268-76.
73. Huang TF, Yeh CH, Wu WB. Viper venom components affecting angiogenesis. Haemostasis 2001; 31: 192-206.
74. Hong SY, Lee H, You WK, Chung KH, Kim DS, Song K. The snake venom disintegrin salmosin induces apoptosis by disassembly of focal adhesions in bovine capillary, endothelial cells. Biochem Biophys Res Commun 2003; 302: 502-8.
75. Souza DH, Iemma MR, Ferreira LL, Faria JP, Oliva ML, Zingali RB, et al. The disintegrin-like domain of the snake venom metalloprotease alternagin inhibits alpha2betal integrin-mediated cell adhesion. Arch Biochem Biophys 2000; 384: 341-50.
76. Masuda S, Araki S, Yamamoto T, Kaji K, Hayashi H. Purification of a vascular apoptosis-inducing factor from hemorrhagic snake venom. Biochem Biophys Res Commun 1997; 235: 59-63.
77. Masuda S, Hayashi H, Araki, S. Two vascular apoptosis-inducing proteins from snake venom are members of the metalloproteinase/disintegrin-like family. Eur J Biochem 1998; 253: 36-41.
78. Masuda S, Hayashi H, Atoda H, Morita T, Araki S. Purification, cDNA cloning and characterization of the vascular apoptosis-inducing protein, HV1, from Trimeresurus flavoviridis. Eur J Biochem 2001; 268: 3339-45.
79. Trummal K, Tonismagi K, Siigur E, Aaspollu A, Lopp A, Sillat T, et al. A novel metalloprotease from Vipera lebetina venom induces human endothelial cell apoptosis. Toxicon 2005; 46: 46-61.
80. Araki S, Masuda S, Maeda H, Ying MJ, Hayashi H. Involvement of specific integrins in apoptosis induced by vascular apoptosis-inducing protein 1. Toxicon 2002; 40: 535-42.
81. Masuda S, Ohta T, Kaji K, Fox JW, Hayashi H, Araki S. cDNA cloning and characterization of vascular apoptosis-inducing protein 1. Biochem Biophys Res Commun 2000; 278: 197-204.
82. You WK, Seo HJ, Chung KH, Kim DS. A novel metalloprotease from Gloydius halys venom induces endothelial cell apoptosis through its protease and disintegrin-like domains. J Biochern 2003; 134: 739-49.
83. Tanjoni I, Weinlich R, Della Casa MS, Clissa PB, Saldanha-Gama RF, Freitas MS, et al. Jararhagin, a snake venom toxin, induces a specialized form of apoptosis (anoikis) selective to endothelial cells. Apoptosis 2005; 10: 851-61.
84. Schattner M, Fritzen M, Ventura JS, Modesto JCA, Pozner RG, Moura-da-Silva AM, et al. The snake venom metalloproteases berythractivase and jararhagin activate endothelial cells. Biol Chem 2005; 396: 369-74.
85. Gutiérrez JM, Romero M, Diaz C, Borkow G, Ovadia M. Isolation and characterisation of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon 1995; 33: 19-29.
86. Watanabe L, Shannon JD, Valente RH, Rucavado A, Alape-Giron A, Kamiguti AS, et al. Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities. Protein Sci 2003; 12: 2273-81.
87. Diaz C, Valverde L, Brenes O, Rucavado A, Gutierrez JM. Characterization of events associated with apoptosis/anoikis induced by snake venom metalloproteinase BaP1 on human endothelial cells. J Cell Biochem 2005; 94: 520-8.
88. Wu WB, Chang SC, Liau MY, Huang TF. Purification, molecular cloning and mechanism of action of graminelysin I, a snake-venom-derived metalloproteinase that induces apoptosis of human endothelial cells. Biochem J 2001; 357: 719-28.
89. Wu WB, Huang TF. Activation of MMP-2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis. Exp Cell Res 2003; 288: 143-57.
90. Silva MB, Schattner M, Ramos CR, Junqueira-de-Azevedo IL, Guarnieri MC, Lazzari MA, et al. A prothrombin activator from Bothrops crythromelas (jararaca-da-3cca) snake venom: characterization and molecular cloning. Biochem J 2003; 369: 129-39.
91. Cominetti MR, Terruggi CH, Ramos OH, Fox JW, Mariano-Oliveira A, De Freitas MS, et al. Alternagin-C, a disintegrin-like protein, induces vascular endothelial cell growth factor (VEGF) expression and endothelial cell proliferation in vitro. J Biol Chem 2004; 279: 18247-55.
92. Selistre-de-Araujo HS, Cominetti MR, Terruggi CH, Mariano-Oliveira A, De Freitas MS, Crepin M, et al. Alternagin-C, a disintegrin-like protein from the venom of Bothrops alternatus, modulates alpba2beta1 integrin-mediated cell adhesion, migration and proliferation. Braz J Med Biol Res 2005; 38: 1505-11.
93. Zigrino P, Kamiguti AS, Eble J, Drescher C, Nischt R, Fox JW, et al. The reprolysin jararhagin, a sniake venom metalloproteinase, functions as fibrillar collagen agonist involved in fibroblast adhesion and signaling. J Biol Chem 2002; 277: 40528-35.
94. Gallagher P, Bao Y, Serrano SM, Laing GD, Theakston RD, Gutierrez JM, et al. Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: In vitro and in vivo gene expression analysis of the effects of the toxin, Arch Biochem Biophys 2005; 441: 1-15.
95. Ho PL, Serrano SM, Chudzinski-Tavassi AM, Moura da Silva AM, Mentele R, Caldas C, et al. Angiostatin-like molecules are generated by snake venom metalloproteinases. Biochem Biophys Res Commun 2002; 294: 879-85.
96. Gutiérrez JM, Lomonte B. In: RM Kini, Ed, Venom phospholipase A2 enzymes: Structure, function and mechanism: Phospholipase A2 myotoxins from Bothrops snake venoms. Wiley, Chichester 1997; 321-52.
97. Mebs D, Ownby CL. Myotoxic components of snake venoms: their biochemical and biological activities. Pharmacol Ther 1990; 48: 223-36.
98. Petricevich VL, Teixeir CFP, Tambourgi DV, Gutierrez JM. Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca venoms. Toxicon 2000; 38: 1253-66.
99. Zamunér SR, Gutiérrez JM, M̧uscará MN, Teixeira SA, Teixeira CFP. Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon 2001; 39: 1505-13.
100. Rucavado A, Núñez J, Gutiérrez JM. Blister formation and skin damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int J Exp Pathol 1998; 79: 245-54.
101. Rucavado A, Escalante T, Teixeira CF, Fernandes CM, Diaz C, Gutierrez JM. Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissue-damaging toxins from the venom of the snake Bothrops asper. Mediators Inflamm 2002; 11: 121-8.
102. Farsky SH, Gonçalves LR, Gutierrez JM, Correa AP, Rucavado A, Gasque P, et al. Bothrops asper snake venom and its metalloproteinase BaP-1 activate the complement system. Role in leucocyte recruitment. Mediators Inflamm 2000; 9: 213-21.
103. Rodrigues FG, Petretski JH, Kanashiro MM, Lemos L, da Silva WD, Kipnis TL. The complement system is involved in acute inflammation but not in the hemorrhage produced by a Bothrops atrox snake venom low molecular mass proteinase. Mol Immunol 2004; 40: 1149-56.
104. Costa EP, Clissa PB, Teixeira CFP, Moura-da-Silva AM. Importance of metalloproteinases and macrophages in viper snake envenomation-induced local inflammation. Inflammation 2002; 26: 13-7.
105. Dale S, Gonçalves LRC, Juliano L, Juliano MA, Moura-da-Silva AM, Giorgi R. The C-terminus of murine S100A9 inhibits hyperalgesia and edema induced by jararhagin. Peptides 2004; 25: 81-89.
106. Maria DA, Vassao RC, Ruiz IRG. Haempoietic effects induced in mice by the snake venom toxin jararhagin. Toxicon 2003; 42: 579-85.
107. Silva CA, Zuliani JP, Assakura MT, Mentele F, Camargo AC, Teixeira CF, et al. Activation of alphaM beta2-mediated phagocytosis by HF3, a PIII class metalloproteinase isolated from the venom of Bothrops jararaca. Biochem Biophys Res Commun 2004; 322: 950-6.
108. Moura-dal-Silva AM, Laing GD, Paine MJI, Dennison JMTV, Politi V, Crampton J M, et al. Processing of pro-tumor necrosis factor-α by venom metalloproteinases: a hypothesis explaining tissue damage following snake bite. Eur J Immunol 1996; 26: 2000-5.
109. Clissa PB, Laing GD, Theakston RDG, Mota I, Taylor MJ, Moura-da-Silva AM. The effect of jararhagin, a metalloproteinase from Bothrops jararaca venom, on pro-inflammatory cytokines released by murine peritoneal adherent cells. Toxicon 2001; 39: 1567-73.
110. Laing GD, Clissa PB, Theakston RDG, Moura-da-Silva AM, Taylor MJ. Inflammatory pathogenesis of snake venom metalloproteinase-induced skin necrosis. Eur J Immunol 2003; 33: 3458-63.
111. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998; 10: 602-8.
112. Moura-da-Silva AM, Della-Casa MS, David AS, Assakura MT, Butera D, Lebrun I, et al. Evidence for heterogeneous forms of the snake venom metalloproteinase jararhagin: a factor contributing to snake venom variability. Arch Biochem Biophys 2003; 409: 395-401.
113. Clissa PB, Lopes-Ferreira M, Della-Casa MS, Farsky S, Moura-da-Silva AM. Importance of jararhagin disintegrin-like and cysteine-rich domains in the early events of local inflammatory response. Toxicon 2006; 47: 591-6.
114. Mariano-Oliveira A, Coelho AL, Terruggi CH, Selistre-de-Araujo HS, Barja-Fidalgo C, De Freitas MS. Alternagin-C, a nonRGD-disintegrin, induces neutrophil migration via integrin signaling. Eur J Biochem 2003; 270: 4799-808.
115. Barja-Fidalgo C, Coelho AL, Saldanha-Gama R, Helal-Neto E, Mariano-Oliveira A, Freitas MS. Disintegrins: integrin selective ligands which activate integrin-coupled signaling and modulate leukocyte functions. Braz J Med Biol Res 2005; 38: 1513-20.
116. Tseng YL, Peng HC, Huang TF. Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production. J Biomed Sci 2004; 11: 683-91.
117. Smith JB, Theakston RDG, Coelho AL, Barja-Fidalgo C, Calvete JJ, Marcinkiewicz C. Characterization of a monomeric disintegrin, ocellustatin, present in the venom of the Nigerian carpet viper, Echis ocellatus. FEBS Lett 2002; 51: 950-6.
118. Coelho AL, De Freitas MS, Mariano-Oliveira A, Rapozo DC, Pinto LF, Niewiarowski S, et al. RGD- and MLD-disintegrins, jarastatin, and EC-3, activate integrin-mediated signaling modulating neutrophils chemotaxis, apoptosis and IL-8 gene expression. Exp Cell Res 2004; 292: 371-84.